Healthcare - Medical - Pharmaceuticals - NASDAQ - US
$ 25.3
-0.472 %
$ 1.83 B
Market Cap
None
P/E
CASH FLOW STATEMENT
3.84 M
OPERATING CASH FLOW
-153 M
INVESTING CASH FLOW
127 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Harrow Health, Inc. 8.625% Senior Notes due 2026
| Net Income | -24.4 M |
| Depreciation & Amortization | 12.3 M |
| Capital Expenditures | -153 M |
| Stock-Based Compensation | 15.7 M |
| Change in Working Capital | -7.14 M |
| Others | 3.09 M |
| Free Cash Flow | -149 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | May-2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||||
| Net Income | (24.4) | (14.1) | (18.0) | (3.4) | (0.1) | 14.6 | (12.0) | (19.1) | (15.9) | (10.1) | (7.6) | (5.4) | (1.0) | (2.5) | (4.6) | (3.3) | (4.3) | 46.2 K |
| Depreciation & Amortization | 12.3 | 3.7 | 2.4 | 2.7 | 2.7 | 1.8 | 1.8 | 1.4 | 0.6 | 85.3 K | 5.66 K | 2.94 K | 338 | 1.06 K | 1.06 K | 704 | 0.2 | 0 |
| Deferred Income Tax | 0 | 0 | 14.5 | 2.2 | (2.4) | (22.5) | (0.9) | (0.1) | 0 | (2.6) | (0.3) | 1.2 | 60.3 K | 0.2 | (0.5) | (0.6) | (0.2) | 0 |
| Stock Based Compensation | 15.7 | 8.0 | 5.7 | 2.8 | 2.0 | 2.6 | 2.9 | 3.7 | 3.4 | 2.6 | 3.1 | 2.2 | 0.2 | 0.7 | 0.5 | 0.6 | 0.2 | 0 |
| Other Operating Activities | 7.3 | 9.7 | 0.7 | 0.8 | 0.5 | 0.6 | (1.3) | 3.6 | 0.4 | 2.6 | 0.3 | 24.7 K | 0.3 | 55.5 K | 0.5 | 0.9 | 1.8 | 1.2 K |
| Change in Working Capital | (7.1) | (5.6) | (0.3) | (6.3) | (1.7) | 3.4 | 0.7 | (0.7) | 0.3 | 0.4 | 63.5 K | 0.1 | 0.2 | (0.7) | 0.4 | (0.1) | 0.5 | 4.95 K |
| Cash From Operations | 3.8 | 1.7 | 5.1 | (1.1) | 0.9 | 0.7 | (8.8) | (11.2) | (11.1) | (7.1) | (4.4) | (1.9) | (0.3) | (2.3) | (3.6) | (2.5) | (1.8) | 40.1 K |
| INVESTING CASH FLOW | ||||||||||||||||||
| Capital Expenditures | (152.6) | (7.8) | (28.5) | (1.0) | (1.8) | (2.2) | (1.1) | (7.1) | (1.2) | (0.2) | 20 K | 15.5 K | 0 | 0 | 0 | 3.15 K | 0 | 0 |
| Other Items | 0 | 6.0 | 9.8 | 13 K | 4 K | 4 K | 0.1 | (0.1) | (4.0) | (0.7) | 50 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (152.6) | (1.7) | (18.7) | (1.0) | (1.8) | (2.2) | (1.0) | (7.3) | (5.1) | (0.9) | 70 K | 15.5 K | 0 | 0 | 0 | 3.15 K | 0 | 0 |
| FINANCING CASH FLOW | ||||||||||||||||||
| Common Stock Repurchased | 0 | 0 | (11.0) | 29 K | 0 | 0 | 0 | 0 | 0 | 13 K | 191 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 74.6 | 31.7 | 71.1 | 1.5 | (1.5) | (0.7) | 0.9 | (0.3) | 9.2 | 10 K | 0 | 0.5 | 0.3 | 1.0 | 0 | 0 | 1.5 | 0 |
| Dividends Paid | 0 | 0 | (0.1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.2) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (12.6) | (0.2) | (19.5) | 0 | (0.3) | 4.2 | 27 K | 4.4 | 1.1 | 862 | 0 | 50 K | (0.2) | 0 | 0 | 0 | 0.1 | 0 |
| Cash From Financing Activities | 126.5 | 54.1 | 51.5 | 1.4 | (1.0) | 4.1 | 4.9 | 24.7 | 10.7 | 0.6 | 10.1 | 11.8 | 0.1 | 1.0 | 49.5 K | 3.9 | 5.5 | 0 |
| CHANGE IN CASH | ||||||||||||||||||
| Net Change In Cash | (22.2) | 54.1 | 37.9 | (0.6) | (1.9) | 2.6 | (4.8) | 6.2 | (5.5) | (7.4) | 5.5 | 9.9 | (0.1) | (1.3) | (3.5) | 1.4 | 3.7 | (6.8) |
| FREE CASH FLOW | ||||||||||||||||||
| Free Cash Flow | (148.7) | (6.1) | (23.4) | (2.1) | (0.9) | (1.5) | (9.9) | (18.4) | (12.3) | (7.2) | (4.5) | (1.9) | (0.3) | (2.3) | (3.6) | (2.5) | (1.8) | 40.1 K |